Juxtarenal Aortic Aneurysm
Outcome Juxtarenal Aortic Aneurysm After Open Repair
1 other identifier
observational
200
0 countries
N/A
Brief Summary
All patients with a juxtarenal abdominal aortic aneurysm who underwent open aneurysm therapy between January 2010 and July 2020 were included retrospectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
November 20, 2024
CompletedFirst Posted
Study publicly available on registry
May 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 23, 2025
May 1, 2025
11 years
November 20, 2024
May 15, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Mortality
Mortality after 30 days postop
30 days after intervention
Acute renal failure
Acute renal failure postoperatively, defined by KDIGO criteria of AKI \[22890468\]
30 days after intervention
Secondary Outcomes (5)
Dialysis
during Follow up period, checked every year
Reinterventions
during Follow up period, checked every year
Mortality
during Follow up period (up to 13 years)
Aneurysm-related Mortality
during Follow up period (up to 13 years)
Post-operative complication rates
During Follow-up period (up to 13 years)
Eligibility Criteria
All patients with a juxtarenal aneurysm who fulfill the inclusion criteria or do not fulfill the exclusion criteria may be included in this study
You may qualify if:
- Patients with a juxtarenal aneurysm (defined as infrarenal neck \<10mm and clamping above at least one renal artery \[31592091\])
- Open therapy with infrarenal (Anschluss)
- \>18 years
You may not qualify if:
- Patients with an anastomosis above the renal arteries (e.g. including bypass to a renal artery)
- Patients with supravisceral clamping
- Patients with reconstruction of the aorta in the suprarenal area
- Patients with connective tissue diseases (e.g. Marfan syndrome or Ehler Danlos syndrome)
- Post-dissection aneurysms
- Infected aneurysms
- Conversions after endovascular therapy
- Inflammatory aneurysms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Muensterlead
- University Hospital Augsburgcollaborator
- University Hospital, Aachencollaborator
- Goethe Universitycollaborator
- University Hospital Heidelbergcollaborator
- University Hospital Regensburgcollaborator
- University of Hamburg-Eppendorfcollaborator
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Univ.-Prof. Dr. med.
Study Record Dates
First Submitted
November 20, 2024
First Posted
May 23, 2025
Study Start
January 1, 2010
Primary Completion
December 31, 2020
Study Completion
December 31, 2025
Last Updated
May 23, 2025
Record last verified: 2025-05